ICIS Open Science SM Card-ver2

Asthma Initiative

Asthma is a chronic respiratory condition that affects the airways in the lungs, causing them to become inflamed, narrowed, and filled with mucus.

Phase I
Systems Architecture
Systems Architecture
Status: In Progress
The Systems Architecture of Asthma is published as a web based tool open to public.
Phase II
Publications
Publications
Status: Open
A peer-reviewed paper from the Asthma Initiative will be published soon. This phase is yet to begin.
Phase III
In Silico Modeling
In Silico Modeling
Status: Open
In this phase, in silico modeling will develop mathematical models of Asthma pathogenesis. This phase is in progress.
Phase IV
Combination Screening
Combination Screening
Status: Open
Combination Screening will be conducted to identify compounds targeting biological processes in Asthma pathogenesis.
Phase V
Patents
Patents
Status: Open
In this phase, a US patent will be filed for the newly discovered combination(s).
Phase VI
Licensing and Manufacturing
Licensing and Manufacturing
Status: Open
The Oral health Initiative will license and manufacture nutraceuticals to support treatment of Asthma.

The Open Science Institute’s Asthma Initiative has now progressed to the second phase — Publication. We need your support to move forward. Our goal is to raise $50,000 to research and reveal to the scientific community, highlighting the powerful potential of natural ingredients on Asthma. Please support this initiative.

Background on Asthma

Asthma is a chronic respiratory condition that affects the airways in the lungs, causing them to become inflamed, narrowed, and filled with mucus. This inflammation makes it difficult for air to move in and out of the lungs, leading to symptoms such as wheezing, shortness of breath, chest tightness, and coughing. Asthma can be triggered by various factors including allergens, air pollution, cold air, exercise, and respiratory infections. While the severity of asthma varies from person to person, it can range from mild to life-threatening if not properly managed. Although there is no cure for asthma, it can be effectively controlled through a combination of medication, lifestyle changes, and avoiding known triggers. Regular monitoring and working closely with healthcare providers help individuals lead active, healthy lives. Education and awareness are also key to managing asthma and reducing its impact on daily life.

Systems Architecture

The Systems Architecture of Asthma will be published as a web-based tool, open to the public. While development is yet to commence.

Publication

A peer-reviewed publication from the Asthma initiative will be released soon to benefit the public by revealing powerful insights into the use of Natural ingredient against the Asthma—support this initiative to advance scientific discovery and deliver real solutions to the society.

In Silico Modeling

In this phase, the Asthma health Initiative will conduct in silico modeling to identify and test the efficacy of compounds on Inflammation, Anti-Fibrosis and Mucus hypersecretion activity. This phase is yet to begin.

Combination Screening

In this phase, the Asthma health Initiative will conduct in silico modeling to identify and test the efficacy of compounds on Inflammation, Anti-Fibrosis and Mucus hypersecretion activity. This phase is yet to begin.

Patents

The Open Science Institute® through its Asthma health initiative is moving towards getting patents for a revolutionary novel compounds that affects Inflammation, Anti-Fibrosis and Mucus hypersecretion activity. This phase is yet to begin.

Licensing and Manufacturing

The Asthma health Initiative plans to discover, develop, license and manufacture a Asthma health product which supports treatment of Asthma. Support our mission to bring this innovation to those who need it most. Please support this Phase by donating to the Asthma health Initiative

Health-produc_Edited (1)